Many roads lead to MPN

Abstract

In this issue of Blood, Lundberg et al correlate the presence of known mutations in patients with myeloproliferative neoplasms (MPNs) with clinical outcome, thereby proposing a molecular risk stratification. © 2014 by The American Society of Hematology.